Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · Real-Time Price · USD

196.31

+4.92 (2.57%)

Feb 26, 2026, 3:14 PM EST - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Development and Licensing of Biopharmaceutical Assets	167.13M	131.31M	196.25M	241.54M	163.56M
Development and Licensing of Biopharmaceutical Assets Growth	27.28%	-33.09%	-18.75%	47.68%	35.98%
Total	167.13M	131.31M	196.25M	241.54M	163.56M
Total Growth	27.28%	-33.09%	-18.75%	47.68%	35.98%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	167.13M	131.31M	196.25M	241.54M	163.56M
United States Growth	27.28%	-33.09%	-18.75%	47.68%	35.98%
Total	167.13M	131.31M	196.25M	241.54M	163.56M
Total Growth	27.28%	-33.09%	-18.75%	47.68%	35.98%

Source: S&P Global Market Intelligence.